Update on new developments in the study of human teratogens

Teratology

Volumn 65, Issue 4, 2002, Pages 153-161

  Shepard, T H ^a   Brent, R L ^b   Friedman, J M ^c   Jones, K L ^d   Miller, R K ^e   Moore, C A ^f   Polifka, J E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^f NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CARBIMAZOLE; CORTISONE; GLUCOCORTICOID; LITHIUM; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE; PREDNISONE; TERATOGENIC AGENT; THIAMAZOLE; TRIMETHOPRIM; VALPROIC ACID;

ALCOHOL CONSUMPTION; BIRTH DEFECT; CIGARETTE SMOKING; CLEFT PALATE; CLUBFOOT; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; FETUS MALFORMATION; GENOTYPE; HIGH RISK POPULATION; HUMAN; MEDICAL RESEARCH; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; FEMALE; HUMANS; PREGNANCY; RISK; TERATOGENS;

EID: 0036128664     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.10032     Document Type: Review

References (99)

1. Seizure disorders in pregnancy
2. Single-dose antibacterial treatment for bacteriuria in pregnancy
3. Identifying maternal disorders self-reported alcohol use associated with the fetal alcohol spectrum alcoholism
4. Testing for interaction between maternal smoking and TGFA genotype among oral cleft cases born in Maryland 1992-1996
5. Steroids during pregnancy and possible fetal consequences
6. Maternal corticosteroid use and the risk for selected anomalies
7. Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate
8. Cognitive and behavioral deficits in non-human primates associated with very early embryonic binge exposures to ethanol
9. Methimazole embryopathy. Delineation of the phenotype
10. A reevaluation of the risk of in utero exposure to lithium
11. A study of the use in pregnancy of co-trimoxazole and sulfamethizole
12. A case-control analysis of the teratogenic effects of co-trimoxazole
13. Population based case control study of the teratogenic potential of corticosteroids
14. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene
15. Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies
16. The fetal valproate syndrome
17. Teratology: General considerations and principles
18. Smoking and reproduction. Short and long term effects and benefits of smoking cessation
19. Head circumference in children of epileptic mothers: Contributions of drug exposure and genetic background
20. Intelligence of children of epileptic mothers
21. Specific cognitive dysfunction in children with epileptic mothers
22. Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse and risk of craniosynostosis
23. Reproductive risks of binge drinking during pregnancy
24. Choanal atresia: Methimazole teratogenicity or a new syndrome?
25. Folic acid antagonists during pregnancy and the risk of birth defects
26. Neural tube defects in relation to use of folic acid antagonists during pregnancy
27. Fetal head growth retardation associated with maternal antiepileptic drugs
28. Family history, maternal smoking and clubfoot. An indication of gene environment interaction
29. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester
30. Relation to maternal age and pattern of pregnancy drinking to functionally significant cognitive deficit in infancy
31. Are antiepileptic drugs harmful when taken during pregnancy?
32. A tier system for developmental toxicity evaluations based on considerations of exposure and effect relationships
33. Outcome of pregnancy in women who "binge" drink during the first trimester of pregnancy
34. Pattern of malformations in the children of women treated with carbamazepine during pregnancy
35. Genetic maternal effects on cleft lip frequency in A/J and CL/Fr mice
36. Lithium and pregnancy: A cohort on manic-depressive women
37. Maternal smoking and orofacial clefts
38. Teratogenicity of antiepileptic drugs and drug specific malformations
39. Congenital malformations due to antiepileptic drugs
40. Microencephaly and hyperactivity in adult rats can be induced by neonatal exposure to high blood alcohol concentrations
41. 1999 Warkany lecture. Improving the science of predicting risks to children's health
42. Valproic acid embryopathy: Report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature
43. Syndromal and nonsyndromal primary trigonocephaly: Analysis of 237 patients
44. Teratogen update: Valproic acid
45. Maternal cigarette smoking during pregnancy and risk of oral clefts in newborns
46. Tobacco and alcohol use during pregnancy and risk of oral clefts. Occupational Exposure and Congenital Malformation Working Group
47. Ectodermal abnormalities associated with methimazole intrauterine exposure
48. Septo-optic dysplasia as a manifestation of valproic acid embryopathy
49. Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy
50. Maternal methimazole and congenital defects in children
51. An assessment of lithium using the IEHR evaluative process for assessing human developmental and reproductive toxicity of agents
52. A clinical study of 57 children with fetal anticonvulsant syndromes
53. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole
54. Lithium, Epstein's anomaly and other congenital heart defects
55. Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: Independent effects of epilepsy and medications
56. Effects of moderate alcohol consumption during pregnancy on child development at 18 and 42 months
57. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort
58. Teratogen update: Antithyroid drugs. Methimazole and propylthiouracil
59. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy
60. Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies
61. A pregnancy register of patients receiving carbamazepine in the UK
62. Esophageal atresia and tracheoesophageal fistula in two infants born to hyperthyroid women receiving methimazole (Tapazole) during pregnancy
63. Maternal valproic acid and congenital neural tube defects
64. Malformation surveillance and maternal drug exposure: The Madre Project
65. Prenatal exposure to valproic acid during pregnancy and limb deficiencies: A case-control study
66. Corticosteroids during pregnancy and oral clefts: A case-control study
67. Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: Evaluation of genotype-environment interactions from a population-based case-control study of orofacial clefts
68. Personal communication
69. Spina bifida in infants of women treated with carbamazepine during pregnancy
70. Antiepileptic drug regimens and major congenital abnormalities in the offspring
71. Maternal use of antiepileptic drugs and the risk of major congenital malformations: A joint European prospective study of human teratogenesis associated with maternal epilepsy
72. What happened later to lithium babies? A follow-up study of children born without malformations
73. Lithium teratogenicity
74. Reproductive effects of chemical, physical and biologic agents
75. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy (Erratum: JAMA 271:1745)
76. Corticotherapie et grossesse
77. Congenital malformations before and after the onset of maternal epilepsy
78. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants
79. Prenatal alcohol and offspring development: The first 14 years
80. Fetal alcohol syndrome in a mouse model
81. Occasional binges by moderate drinkers: Implications for birth outcomes
82. Antiepileptic medication in pregnancy: Late effects on the children's central nervous system development
83. Smoking, genetic, polymorphisms in biotransformation enzymes, and nonsyndromic oral clefting: A gene-environment interaction
84. Risk of recurrence of bipolar disorder in nonpregnant women after discontinuing lithium maintenance
85. Lithium teratogenesis
86. Teratogen update: Smoking and reproductive outcomes
87. Psychomotor development and minor anomalies in children exposed to antiepileptic drugs in utero: A prospective population-based study
88. Fetal valproate syndrome and autism: Additional evidence of an association
89. The treatment of bacteriurea in pregnant women with sulphamethoxazole and trimethoprim
90. Choanal atresia and hypothelia following methimazole exposure in utero: A second report
91. Comparison of propylthiouracil vs. methimazole in the treatment of hyperthyroidism in pregnancy
92. Maternal cigarette smoking and oral clefts. A meta-analysis